Metabolic Unit - Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands.
J Inherit Metab Dis. 2012 Jul;35(4):571-87. doi: 10.1007/s10545-012-9462-5. Epub 2012 Mar 6.
The organic acidurias D: -2-hydroxyglutaric aciduria (D-2-HGA), L-2-hydroxyglutaric aciduria (L-2-HGA), and combined D,L-2-hydroxyglutaric aciduria (D,L-2-HGA) cause neurological impairment at young age. Accumulation of D-2-hydroxyglutarate (D-2-HG) and/or L-2-hydroxyglutarate (L-2-HG) in body fluids are the biochemical hallmarks of these disorders. The current review describes the knowledge gathered on 2-hydroxyglutaric acidurias (2-HGA), since the description of the first patients in 1980. We report on the clinical, genetic, enzymatic and metabolic characterization of D-2-HGA type I, D-2-HGA type II, L-2-HGA and D,L-2-HGA, whereas for D-2-HGA type I and type II novel clinical information is presented which was derived from questionnaires.
有机酸血症 D:-2-羟戊二酸血症 (D-2-HGA)、L-2-羟戊二酸血症 (L-2-HGA) 和 D,L-2-羟戊二酸血症 (D,L-2-HGA) 都会导致患者在年幼时出现神经损伤。这些疾病的生化特征是体液中 D-2-羟戊二酸 (D-2-HG) 和/或 L-2-羟戊二酸 (L-2-HG) 的积累。本文回顾了自 1980 年首次描述这些患者以来 2-羟戊二酸血症 (2-HGA) 的研究进展。我们报告了 D-2-HGA 型 I、D-2-HGA 型 II、L-2-HGA 和 D,L-2-HGA 的临床、遗传、酶学和代谢特征,其中 D-2-HGA 型 I 和型 II 还呈现了从调查问卷中得出的新的临床信息。